In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)
Aim for adequate water intake throughout the day, especially before meals
If a product doesnt clearly list this ratioor worse, doesnt show dosage amounts on the backthats a red flag
PubMed Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW
The combined power of these three ingredients accomplishes what you cant on your own: melting away unwanted fat and giving you the body that you have always wanted
You are encouraged to report negative side effects to the FDA